- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Advances in Pharmacological Sciences
Volume 2012 (2012), Article ID 529861, 2 pages
Receptor Subtypes: Novel Targets for Novel Medicines
1Neuro Search A/S, Pederstrupvej 93, 2750 Ballerup, Denmark
2Johnson & Johnson Pharmaceutical Research and Development, 30 Turnhoutseweg, B-2340 Beerse, Belgium
3Eli Lilly UK, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK
Received 14 December 2011; Accepted 14 December 2011
Copyright © 2012 Naheed R. Mirza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. L. Speaker, “From "happiness pills" to "national nightmare": changing cultural assessment of minor tranquilizers in America, 1955–1980,” Journal of the History of Medicine and Allied Sciences, vol. 52, no. 3, pp. 338–376, 1997.
- J. M. Gorman, “Benzodiazepines: taking the good with the bad and the ugly,” CNS Spectrums, vol. 10, no. 1, pp. 14–15, 2005.
- U. Rudolph and F. Knoflach, “Beyond classical benzodiazepines: novel therapeutic potential of GABA A receptor subtypes,” Nature Reviews Drug Discovery, vol. 10, no. 9, pp. 685–697, 2011.
- R. W. Olsen and W. Sieghart, “International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update,” Pharmacological Reviews, vol. 60, no. 3, pp. 243–260, 2008.